Roflumilast Cream 0.15% in Patients with Atopic Dermatitis: Individual Patient Response from the Pooled INTEGUMENT-1 and INTEGUMENT-2 Phase 3 Trials. J of Skin. 2024;8(2):s372. doi:10.25251/skin.8.supp.372